KEGG pathway enrichment analysis of lactoferrin and Coenzyme Q10 in sarcopenia. حسب Wenbin Wu (292223)

الموضوعات:

Ultimate analysis and proximate analysis of lignite. حسب Xinhui Luo (11880086)

الموضوعات:

Contact angle between solid and liquid. حسب Xinhui Luo (11880086)

الموضوعات:

Diagram of the experimental equipment. حسب Xinhui Luo (11880086)

الموضوعات:

Effects of lactoferrin and Coenzyme Q10 on skeletal muscle of mice. حسب Wenbin Wu (292223)

الموضوعات:

Each group’s performance on behavioral tests. حسب Wenbin Wu (292223)

الموضوعات:

Contact angle of surfactants at different concentrations;(a) Anionic surfactants, (b) Nonionic surfactants, (c) Amphoteric surfactants. حسب Xinhui Luo (11880086)

الموضوعات:

The 12 kinds of surfactants selected in the experiment. حسب Xinhui Luo (11880086)

الموضوعات:

Sedimentation experimental device. حسب Xinhui Luo (11880086)

الموضوعات:

Parameters for the treadmill during the testing phase. حسب Wenbin Wu (292223)

الموضوعات:

Transcriptome sequencing enriched sarcopenia related GO Biological process (BP) and Molecular function (MF). Enriched GO BP of DEGs. حسب Wenbin Wu (292223)

الموضوعات:

The wetting feature of compound solutions. حسب Xinhui Luo (11880086)

الموضوعات:

S1 Data - Synergistic effects of surfactant blends on lignite dust wettability حسب Xinhui Luo (11880086)

الموضوعات:

Sedimentation velocity of surfactants at different concentrations. حسب Xinhui Luo (11880086)

الموضوعات:

HE staining of the gastrocnemius muscle. حسب Wenbin Wu (292223)

الموضوعات:

Surface tension of surfactants at different concentrations;(a) Anionic surfactants, (b) Nonionic surfactants, (c) Amphoteric surfactants. حسب Xinhui Luo (11880086)

الموضوعات:

Absorption peaks of groups. حسب Xinhui Luo (11880086)

الموضوعات:

qPCR verified the expression changes of GO and KEGG pathway enriched sarcopenia related DEGs. حسب Wenbin Wu (292223)

الموضوعات:

Infrared spectrogram of lignite. حسب Xinhui Luo (11880086)

الموضوعات:

Join-point regression analysis of the statistically significant linear decrease in use of antidepressants, antipsychotics, psychostimulants and nootropic drugs, anxiolytics, sedatives and hypnotics during the observed time period. حسب Jelena Filimonovic (22305307)

الموضوعات: